Readily Diagnostics Overview

  • Year Founded
  • 2022

Year Founded

  • Status
  • Private

  • Employees
  • 10

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $1.69M

  • Investors
  • 9

Readily Diagnostics General Information

Description

Developer of diagnostic testing designed for infectious diseases. The company's method uses padlock probes for target recognition, followed by isothermal amplification of reacted probes via rolling circle implication, allowing healthcare professionals to quicker and more effectively treat patients with respiratory diseases.

Contact Information

Website
www.readily.se
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Husargatan 3
  • BMC D7:5
  • Uppsala
  • Sweden
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • Husargatan 3
  • BMC D7:5
  • Uppsala
  • Sweden

Readily Diagnostics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Readily Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 30-Oct-2024 $1.69M Completed Generating Revenue
3. Accelerator/Incubator 28-Jun-2024 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2024 $929K Completed Generating Revenue
1. Early Stage VC 10-Jun-2023 $929K $929K Completed Generating Revenue
To view Readily Diagnostics’s complete valuation and funding history, request access »

Readily Diagnostics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
Ordinary
Ordinary
To view Readily Diagnostics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Readily Diagnostics Patents

  • 15

    Total Documents Applications and Grants

  • Total Patents Families

  • 8

    Granted

  • 5

    Pending

  • Expiring in next 12 mo

Readily Diagnostics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026217030-A1 Method for detecting target nucleic acid molecules Pending 07-Apr-2025
WO-2025216681-A1 Microfluidic device with internal heating Pending 09-Apr-2024
EP-4504967-A1 Method for detecting target nucleic acid molecules Active 03-May-2023
EP-4504967-B1 Method for detecting target nucleic acid molecules Active 03-May-2023
EP-4504967-C0 Method for detecting target nucleic acid molecules Active 03-May-2023 C12Q1/6844
To view Readily Diagnostics’s complete patent history, request access »

Readily Diagnostics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Readily Diagnostics Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
Inter Alia Corporation Minority
Kjell & Märta Beijers Foundation Impact Investing Minority
Länsförsäkringar Limited Partner Minority
Angel (individual) Minority
STUNS Life Science Accelerator/Incubator
You’re viewing 5 of 9 investors. Get the full list »

Ready to get started?

Request a free trial

Readily Diagnostics FAQs

  • When was Readily Diagnostics founded?

    Readily Diagnostics was founded in 2022.

  • Where is Readily Diagnostics headquartered?

    Readily Diagnostics is headquartered in Uppsala, Sweden.

  • What is the size of Readily Diagnostics?

    Readily Diagnostics has 10 total employees.

  • What industry is Readily Diagnostics in?

    Readily Diagnostics’s primary industry is Diagnostic Equipment.

  • Is Readily Diagnostics a private or public company?

    Readily Diagnostics is a Private company.

  • What is the current valuation of Readily Diagnostics?

    The current valuation of Readily Diagnostics is .

  • What is Readily Diagnostics’s current revenue?

    The current revenue for Readily Diagnostics is .

  • How much funding has Readily Diagnostics raised over time?

    Readily Diagnostics has raised $2.62M.

  • Who are Readily Diagnostics’s investors?

    Inter Alia, Kjell & Märta Beijers Foundation, Länsförsäkringar, , and STUNS Life Science are 5 of 9 investors who have invested in Readily Diagnostics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process